Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial (2014)
- Authors:
- Shiffman, Mitchell L.
- Cheinquer, Hugo
- Berg, Christoph P.
- Berg, Thomas
- Figueiredo-Mendes, Claudio de
- Dore, Gregory J.
- Ferraz, Maria Lucia
- Mendes-Correa, Maria Cassia
- Lima, Maria Patelli
- Parise, Edison R.
- Rios, Alma Minerva Perez
- Reuter, Tania
- Sanyal, Arun J.
- Shafran, Stephen D.
- Hohmann, Marc
- Tatsch, Fernando
- Bakalos, George
- Zeuzem, Stefan
- Autor USP: CORRÊA, MARIA CASSIA JACINTHO MENDES - FM
- Unidade: FM
- DOI: 10.1007/s12072-014-9555-3
- Subjects: GENÓTIPOS; HEPATITE CRÔNICA; INTERFERONS; VÍRUS DA HEPATITE C
- Language: Inglês
- Imprenta:
- Source:
- Título: Hepatology International
- ISSN: 1936-0533
- Volume/Número/Paginação/Ano: v. 8, n. 4, p. 517-526, 2014
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
SHIFFMAN, Mitchell L. et al. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, v. 8, n. 4, p. 517-526, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12072-014-9555-3. Acesso em: 11 maio 2026. -
APA
Shiffman, M. L., Cheinquer, H., Berg, C. P., Berg, T., Figueiredo-Mendes, C. de, Dore, G. J., et al. (2014). Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, 8( 4), 517-526. doi:10.1007/s12072-014-9555-3 -
NLM
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2026 maio 11 ] Available from: https://doi.org/10.1007/s12072-014-9555-3 -
Vancouver
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2026 maio 11 ] Available from: https://doi.org/10.1007/s12072-014-9555-3 - Noninvasive models for predicting liver fibrosis in individuals with hepatitis D virus/hepatitis B virus coinfection in the brazilian amazon region
- Evaluation of the utilization of filmArray meningitis/encephalitis in children with suspected central nervous system infection a retrospective case series
- How are HCV-infected patients being identified in Brazil: a multicenter study
- Hepatitis B: prevalence and occult infection in HIV-infected patients
- Hepatitis C disease burden and strategies for elimination by 2030 in Brazil.: a mathematical modeling approach
- Disease burden of chronic hepatitis C in Brazil
- Análise exploratória espacial de casos de HBV no Brasil entre 2005 e 2017
- Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
- Viral hepatitis and HIV: Update and management
- Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
